Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK - Results from micro-simulation model.

Biccler, Jorne; Bollaerts, Kaatje; Vora, Pareen; Sole, Elodie; Rodriguez, Luis Alberto Garcia; Lanas, Angel; Langley, Ruth E; Gabarró, Montse Soriano

Biccler, Jorne; Bollaerts, Kaatje; Vora, Pareen; Sole, Elodie; Rodriguez, Luis Alberto Garcia; Lanas, Angel; Langley, Ruth E; Gabarró, Montse Soriano.

Afiliação

Biccler J; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.
Bollaerts K; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.
Vora P; Bayer AG, Epidemiology, Integrated Evidence Generation, Berlin, Germany.
Sole E; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium.
Rodriguez LAG; Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.
Lanas A; Servicio de Aparato Digestivo, Hospital Clínico, University of Zaragoza, Zaragoza, Spain.
Langley RE; CIBERehd. IIS Aragón, Zaragoza, Spain.
Gabarró MS; MRC Clinical Trials Unit, University College London, London, United Kingdom.

Int J Cardiol Heart Vasc ; 36: 100851, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34401469

Palavras-chave

Aspirin; Cardiovascular disease; Colorectal cancer; Computer simulation; Epidemiology; Risk factors; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cardiol Heart Vasc Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google